Trozet (Femara) Marketing InformationTrozet is sold in pharmcies as "Femara". It is also possible to purchase Femara in online store. Usually it doesn't require doctor's receipt. Trozet also can be sold as: Letrozole, Femar.
Trozet (Femara) General InformationTrozet is used to treat breast cancer in women who are post-menopausal - that is, women who no longer have periods, either naturally due to their age or after surgery or chemotherapy.
Trozet is approved for the adjuvant (following surgery) treatment of postmenopausal women with hormone receptor-positive early stage breast cancer. The benefits of Trozet in clinical trials are based on 24 months of treatment.
Trozet is also approved for the extended adjuvant treatment of early stage breast cancer in postmenopausal women who are within three months of completion of five years of tamoxifen therapy. The benefits of Trozet in clinical trial are based on 24 months of treatment.
In addition, Trozet is approved for the treatment of postmenopausal women with hormone receptor-positive or hormone receptor-unknown breast cancer that has spread to another part of the body (metastatic cancer).
Trozet (Femara) Recommendations
Follow the directions for using this medicine provided by your doctor. Take Trozet exactly as directed.
The usual dose is one Trozet tablet daily.
Swallow the tablet with a glass of water or other liquid.
Your doctor will check your progress to make sure the medicine is working and will decide how long your treatment should continue.
Trozet (Femara) Precautions
Tell your doctor before taking Trozet, if:
you are allergic to any medicines;
you are still having periods;
you have severe kidney or liver disease;
you are pregnant or breast-feeding.
Trozet (Femara) Ingredients
Active ingredient: letrozole.